The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen.

Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The makers of certain tests will benefit both in terms of sales and more broadly in recognition that their products play a vital role in making the public health community significantly better prepared for this possible pandemic than 1968 or before.

The report examines:

• Market Impact likely for immunoassays and molecular testing.
• Lessons from previous epidemics, likely impact on both immunoassays and molecular testing.
• Overview of the H1N1 strain as compared to other.
• Immunoassay and Molecular Test Products Available on the Market
• Developments in the last few days of significance to the diagnostic industry.
• Profiles of nearly 25 specific manufacturers active in this space.

The report focuses almost exclusively on the in vitro diagnostic industry as it applies to work being done by commercial entities and products that are either in development or have been brought to market.

The market assessment provided has been assembled based on publicly available information. Company sales data and other quantitative evaluations of the markets for flu diagnostics have been developed based on publicly available information and are expressed in US dollars, no adjustments have been made for currency exchange fluctuations.

Under normal circumstances, a report of this genre would be assembled from information derived from primary and secondary sources. However, in the short time it took to research and write this report, almost all of the major scientific and industry experts were occupied with the extraordinary task of preparing for a pandemic.

Therefore the information contained in this report has been assembled from a vast array of scientific and market publications, government sources, analyzed by a professional analyst.

Related Reports:

The Worldwide Market for Cancer Diagnostics, 4th Edition
Apr 1, 2010 - KLI2504623 - $4,200.00

Lab Automation Markets, 2nd Edition (Systems, Key Companies, Forecasts and Trends)
Mar 1, 2010 - KLI2601060 - $3,995.00

The Global Market for Medical Devices
Mar 1, 2010 - KLI2592223 - $1,500.00

The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
Feb 1, 2010 - KLI2565239 - $3,500.00

Electrical and Magnetic Neurostimulation: Applications, Technologies, and Market Potential
Feb 1, 2010 - KLI2495102 - $3,500.00

Kalorama Select Diagnostic Market Research Report Package
Jan 15, 2010 - KLI2577676 - $19,999.00

Kalorama Information Library and Annual Subscription
Jan 1, 2010 - KLI1600708 - $55,000.00

Medical Imaging Markets: Contrast Agents
Nov 1, 2009 - KLI2469989 - $3,500.00

Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
Nov 1, 2009 - KLI2403357 - $3,995.00

2009 Worldwide Diagnostics Market Research Bundle
Oct 1, 2009 - KLI2401913 - $5,995.00